Rasu Shrestha
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Rasu Shrestha
Jun 15, 2024, 16:54 |
Blog
Our ongoing series “Current Thinking in Myelofibrosis” received The Spring 2024 Digital Health Award - PeerDirect
Ruben Mesa shared the following post by PeerDirect on LinkedIn: “So honored to have taken part…
Mar 14, 2024, 22:16 |
Blog
Rasu Shrestha: Could not be prouder of Nurse Kris Blackley, and the tremendous work she leads and represents
Rasu Shrestha, Executive Vice President at Advocate Health, shared a post by Chris Berger, Vice President…
Feb 13, 2024, 02:05 |
Blog
Rasu Shrestha: Truly proud to have hosted First Lady Dr Jill Biden as we reaffirm our innovative commitments to reignite the Cancer Moonshot and end cancer as we know it
Rasu Shrestha, Executive Vice President of Advocate Health, shared a LinkedIn post by Ruben Mesa,…
Jan 3, 2024, 10:42 |
Positive
Rasu Shrestha: Be a new, quieter kind of hero
Ruben Mesa, President of Atrium Health Levine Cancer, shared a post by Rasu Shrestha, Executive Vice…
Nov 28, 2023, 22:55 |
Blog
Rasu Shrestha: We’re building the nation’s first net-zero medical school
Rasu Shrestha, Chief Innovation and Commercialization Officer, Executive Vice President at Advocate Health, posted the…
Sep 15, 2023, 19:28 |
Blog
Ruben Mesa: So excited to have our Integrated Cancer Center Atrium Health Wake Forest Baptist Comprehensive Cancer Center and Levine Cancer Institute play a key role in CancerX Moonshot!
Sep 15, 2023, 18:40 |
Blog
Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. - CancerX Moonshot
All:
7
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube